137 related articles for article (PubMed ID: 30952432)
41. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
Schmidt D; Müller S
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
[TBL] [Abstract][Full Text] [Related]
42. PIAS1 negatively regulates ubiquitination of Msx1 homeoprotein independent of its SUMO ligase activity.
Song YJ; Lee H
Mol Cells; 2011 Sep; 32(3):221-6. PubMed ID: 21717107
[TBL] [Abstract][Full Text] [Related]
43. Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9.
Hattori T; Eberspaecher H; Lu J; Zhang R; Nishida T; Kahyo T; Yasuda H; de Crombrugghe B
J Biol Chem; 2006 May; 281(20):14417-28. PubMed ID: 16554309
[TBL] [Abstract][Full Text] [Related]
44. PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus.
Lee JM; Kang HJ; Lee HR; Choi CY; Jang WJ; Ahn JH
FEBS Lett; 2003 Dec; 555(2):322-8. PubMed ID: 14644436
[TBL] [Abstract][Full Text] [Related]
45. Pax8 protein stability is controlled by sumoylation.
de Cristofaro T; Mascia A; Pappalardo A; D'Andrea B; Nitsch L; Zannini M
J Mol Endocrinol; 2009 Jan; 42(1):35-46. PubMed ID: 18974227
[TBL] [Abstract][Full Text] [Related]
46. Reciprocal regulation of Notch and nuclear factor of activated T-cells (NFAT) c1 transactivation in osteoblasts.
Zanotti S; Smerdel-Ramoya A; Canalis E
J Biol Chem; 2011 Feb; 286(6):4576-88. PubMed ID: 21131365
[TBL] [Abstract][Full Text] [Related]
47. SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation.
Li C; Boutet A; Pascariu CM; Nelson T; Courcelles M; Wu Z; Comtois-Marotte S; Emery G; Thibault P
J Proteome Res; 2023 Mar; 22(3):812-825. PubMed ID: 36723483
[TBL] [Abstract][Full Text] [Related]
48. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
[TBL] [Abstract][Full Text] [Related]
49. A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.
Depaux A; Regnier-Ricard F; Germani A; Varin-Blank N
Oncogene; 2007 Oct; 26(46):6665-76. PubMed ID: 17533377
[TBL] [Abstract][Full Text] [Related]
50. SUMO-1 modification of MEF2A regulates its transcriptional activity.
Riquelme C; Barthel KK; Liu X
J Cell Mol Med; 2006; 10(1):132-44. PubMed ID: 16563226
[TBL] [Abstract][Full Text] [Related]
51. Repression of E1AF transcriptional activity by sumoylation and PIASy.
Nishida T; Terashima M; Fukami K; Yamada Y
Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
[TBL] [Abstract][Full Text] [Related]
52. The PHD domain of plant PIAS proteins mediates sumoylation of bromodomain GTE proteins.
Garcia-Dominguez M; March-Diaz R; Reyes JC
J Biol Chem; 2008 Aug; 283(31):21469-77. PubMed ID: 18502747
[TBL] [Abstract][Full Text] [Related]
53. Interaction of protein inhibitor of activated STAT (PIAS) proteins with the TATA-binding protein, TBP.
Prigge JR; Schmidt EE
J Biol Chem; 2006 May; 281(18):12260-9. PubMed ID: 16522640
[TBL] [Abstract][Full Text] [Related]
54. SUMO-Modification of Human Nrf2 at K
Walters TS; McIntosh DJ; Ingram SM; Tillery L; Motley ED; Arinze IJ; Misra S
Cell Physiol Biochem; 2021 Mar; 55(2):141-159. PubMed ID: 33770425
[TBL] [Abstract][Full Text] [Related]
55. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
56. SUMOylation by the E3 ligase TbSIZ1/PIAS1 positively regulates VSG expression in Trypanosoma brucei.
López-Farfán D; Bart JM; Rojas-Barros DI; Navarro M
PLoS Pathog; 2014 Dec; 10(12):e1004545. PubMed ID: 25474309
[TBL] [Abstract][Full Text] [Related]
57. PIASy-mediated repression of the Ets-1 is independent of its sumoylation.
Nishida T; Terashima M; Fukami K
Biochem Biophys Res Commun; 2006 Jul; 345(4):1536-46. PubMed ID: 16729975
[TBL] [Abstract][Full Text] [Related]
58. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
59. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
60. Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.
Ryu H; Azuma Y
J Biol Chem; 2010 Oct; 285(42):32576-85. PubMed ID: 20696768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
